Neumora Therapeutics Inc.... (NMRA)
NASDAQ: NMRA
· Real-Time Price · USD
1.70
-0.13 (-7.10%)
At close: Sep 25, 2025, 3:59 PM
1.70
0.00%
After-hours: Sep 25, 2025, 04:10 PM EDT
-7.10% (1D)
| Bid | 1.66 |
| Market Cap | 275.31M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -252.09M |
| EPS (ttm) | -1.57 |
| PE Ratio (ttm) | -1.08 |
| Forward PE | -1.79 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 1.71 |
| Volume | 364,089 |
| Avg. Volume (20D) | 1,287,714 |
| Open | 1.79 |
| Previous Close | 1.83 |
| Day's Range | 1.68 - 1.81 |
| 52-Week Range | 0.61 - 17.19 |
| Beta | 2.95 |
| Ex-Dividend Date | n/a |
About NMRA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NMRA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NMRA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+13.12%
Neumora Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
4 months ago
-1.89%
NMRA stock has given up its prior gain. Neumora Therapeutics shares were trading higher. The company reported Q1 financial results.
1 month ago · seekingalpha.com
Neumora Therapeutics, Inc. (NMRA) Q2 2025 Earnings Call TranscriptNeumora Therapeutics, Inc. (NASDAQ:NMRA ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Daljit Singh Aurora - Corporate Participant Chief Operationg & Development off...
